Skip to main content

COVID-19-related stigma and its sociodemographic correlates: a comparative study



Coronavirus disease 2019 (COVID-19) is closely associated with physical and mental health problems; however, little is known about the severity of stigma caused by COVID-19 among its survivors. Thus, the aim of this study was to compare differences in stigma experiences of COVID-19 survivors versus healthy controls after the COVID-19 outbreak peak in China.


This cross-sectional study comprised 154 COVID-19 survivors and 194 healthy controls recruited through consecutive and convenience sampling methods, respectively. COVID-19 related stigma was measured by the Social Impact Scale (SIS). Stigma differences between the two groups were compared with analysis of covariance (ANCOVA) and a generalized linear model (GLM) was used to identify independent correlates of COVID-19-related stigma in this study.


Compared with healthy controls, COVID-19 survivors reported more overall stigma (F(1,347) = 60.82, p < 0.001), and stigma in domains of social rejection (F(1,347) = 56.54, p < 0.001), financial insecurity (F(1,347) = 19.96, p < 0.001), internalized shame (F(1,347) = 71.40, p < 0.001) and social isolation (F(1,347) = 34.73, p < 0.001). Status as a COVID-19 survivor, having family members infected with COVID-19, being married, economic loss during the COVID-19 pandemic, and depressive symptoms were positively associated with higher overall stigma levels (all p values < 0.05).


COVID-19-related stigma is commonly experienced among COVID-19 survivors even though the outbreak has been well-contained in China. Routine assessment of stigma experiences should be conducted on COVID-19 survivors and appropriate psychological assistance, public education, and anti-stigma campaigns and policies should be enforced to reduce stigma within this vulnerable subpopulation.


Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Hubei province, China at the end of 2019, and subsequently emerged in other parts of the world [66, 67]. COVID-19 was eventually declared to be a pandemic on 11 March 2020 by the World Health Organization (WHO) [69]. By early November 2020, around 50 million individuals had been infected [28], of whom, over 32 million have recovered from this disease [28]. In China the COVID-19 outbreak has been well controlled nationwide, except for occasional cases imported from overseas since early 2021 [13, 15].

Individuals suffering from COVID-19 may also have common psychiatric comorbidities and related problems such as depression, anxiety, stress and stigma [17, 26, 31, 48, 53, 54, 61]. Stigma refers to disapproval of or negative attitudes toward persons with certain characteristics or diseases that distinguish these persons from other members of society [23, 64]. In contrast, discrimination refers to the act of identifying and treating members of stigmatized groups unfairly compared to members of majority groups [4, 5, 9]. Persons who perceive they are being stigmatized may report guilt, self-blaming behaviour, self-depreciation, self-isolation, low self-esteem, and being excluded or ignored by others [35]. Stigma is closely associated with mental health problems particularly depression. Previous studies have found strong positive associations between stigma and depression; depression and stigma also have certain shared symptoms including feelings of guilt, self-blame, and low self-esteem [12, 52].

During the COVID-19 pandemic, stigma has become a public health challenge. COVID-19 related stigma refers to a disapproving or negative self-attitude, stemming from being infected with, or having close contacts with COVID-19, that results in “a spoiled identity” [41]. Recent findings suggest that some COVID-19 survivors and their family members are rejected by their neighbors, landlords and even employers in China [10]. Certain sub-populations such as persons suspected of having COVID-19, discharged individuals from quarantine, and people returning from overseas also experience various forms of stigmatization including social exclusion, stereotyping and being insulted [2]. Individuals suffering from social stigma may feel ashamed of themselves, and experience self-condemning behaviour or persistent fear of contacting their relatives and friends [10, 17]. For instance, Duan et al. [17] found that 16% of Hubei province residents reported being stigmatized during the peak of the COVID-19 outbreak and felt ashamed, blameworthy and shunned simply because Hubei was the COVID-19 epicenter. Another study from Vietnam found that 18% of healthcare workers felt unsafe to work in healthcare facilities after they undertook quarantine; 10% felt blameworthy by relatives and friends and 34% avoided contacts with neighbors or others in the community due to feeling stigmatized [16].

COVID-19 related stigma can lead to a range of negative consequences such as psychological stress [2], discrimination [18, 39], health-related violence [8, 42] and, worst of all, suicide [56] for affected populations including COVID-19 survivors, suspected or quarantined cases, and people returning from overseas. In addition, COVID-19-related stigma [25] could become a barrier to the control and prevention of COVID-19 because people who experience high levels of stigma are less likely to disclose their health status [2], thus deterring professional help-seeking behaviors [17], and refusing to take COVID-19 tests [19]. As stated by the WHO director-general Dr. Tedros Adhanom Ghebreyesus, “stigma, to be honest, is more dangerous than the [corona] virus itself” [68].

To date, some commentaries and reviews of COVID-19-related stigma have been published [29, 43, 50], but relevant quantitative studies are scant. Thus far, three studies focused on COVID-19-related stigma in healthcare workers [16, 51, 74], and one study investigating stigma in Hubei residents [17] have concluded these groups experience high stigma levels. A qualitative study has also assessed COVID-19-related stigma in two COVID-19 survivors and five family members [2].

Stigma related to infectious diseases is related to clinical features of such diseases and socio-cultural factors [33]. For instance, hepatitis A survivors rarely suffer from stigma yet hepatitis B and C survivors often experience high stigma levels due to more serious long-term effects [14]. Stigma related to infectious diseases is also common in East Asian countries and territories [33]. Previous studies found severe acute respiratory syndrome (SARS) survivors suffered from elevations in mental health problems including stigma in the post-SARS era [40, 57]. Thus, it is reasonable to assume that COVID-19 survivors experience more stigma than do uninfected peers.

Because COVID-19 is caused by a novel virus, it is not clear how widespread or severe stigma is among survivors. To date, no studies have compared COVID-19-related stigma between COVID-19 survivors and healthy controls. Therefore, the aim of this study was to compare COVID-19-related stigma between COVID-19 survivors and healthy controls living in the same region of China and to identify correlates of stigma experiences in these groups.


Study setting and participants

This was a cross-sectional, comparative study conducted between May 27 and September 4, 2020 at Chongqing Mental Health Center (CMHC), a setting that is responsible for follow-up mental health assessments of all COVID-19 survivors in Chongqing Municipality, China. Patients were eligible if they were 1) COVID-19 survivors in Chongqing, China; 2) aged 18 years or above; and 3) able to understand the purpose and contents of the assessment. All COVID-19 survivors attending the follow-up clinic at CMHC were consecutively invited to participate in this study. For the control group (healthy controls hereafter), eligibility criteria were the same except a COVID-19 diagnosis was absent. Healthy controls were recruited via convenience sampling of local community-dwelling residents in Chongqing. The study protocol was approved by the ethics committee of the Chongqing Mental Health Center. All participants provided online informed consent prior to participation.

Assessment tools

The assessment was conducted by a research psychiatrist in a consultation room after participants attended their follow-up assessment. A data collection form was used to collect participant demographic data and clinical characteristics (gender, age, education level, marital status, living circumstances, occupation, perceived economic status, perceived health status). Participants were also asked whether they (1) had any family members infected with COVID-19; 2) perceived online mental health services to be helpful; 3) experienced economic loss during the COVID-19 outbreak; and 4) frequently received information about COVID-19 through social media.

Severity of fatigue was assessed using a fatigue numeric rating scale, which ranged from ‘0’ (no fatigue) to ‘10’ (extreme fatigue) [22]. The nine-item Patient Health Questionnaire (PHQ-9) - Chinese version assessed severity of depressive symptoms [58, 72]. Total PHQ-9 scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.

Experiences of perceived stigma from COVID-19 were measured using the Social Impact Scale (SIS), a widely used 24-item measure of stigmatization used for patients with major medical conditions and infectious diseases such as the human immunodeficiency virus (HIV) [20]. The SIS is a generic stigma scale that can be used for different populations affected by the COVID-19 pandemic. Although healthy controls in the study were not infected with COVID-19, they were also greatly affected widespread quarantine measures during the pandemic such as suspended travel, limited outdoor activities, and school closures. The SIS covers 4 domains, including social rejection (9 items), financial insecurity (3 items), internalized shame (5 items), and social isolation (7 items). Each SIS item is rated from ‘1’ (strongly disagree) to ‘4’ (strongly agree), with total scores ranging from 24 to 96. Higher scores indicate more severe stigma. The Chinese version of the SIS has been validated with good psychometric properties [47].

Statistical analysis

Data were analyzed using Statistical Analysis System (SAS) software, University Edition (SAS Institute Inc., Cary, North Carolina, U.S.). Comparisons of demographics and clinical characteristics between COVID-19 survivors and healthy controls were assessed using independent two sample t tests, Wilcoxon rank sum tests, and chi-square tests, as appropriate. Analyses of covariance (ANCOVA) were used to compare total and subscale SIS score differences between COVID-19 survivors and healthy controls after controlling for other variables on which there were significant group differences.

Associations of demographic and clinical characteristics with SIS total scores were examined using t tests and analysis of variance (ANOVA). A generalized linear model (GLM) was used to explore independent correlates of SIS total scores (the dependent variable) based on measures on which there were significant group differences in univariate analyses (independent variables). Significance level was set at 0.05 (two-tailed tests).


Demographic and clinical characteristics

A total of 158 COVID-19 survivors were invited, of whom, 154 agreed to participate and completed the assessment. In addition, 194 healthy controls were recruited during the study period. Table 1 shows that there were significant differences between COVID-19 survivors and healthy controls in terms of gender, age, education level, employment status, having family members infected with COVID-19, perceptions of online mental services as helpful or not, social media use frequency, economic loss during COVID-19 pandemic, perceived economic status, perceived health status, fatigue total scores, SIS total scores and SIS subscale scores (all p values <0.05).

Table 1 Demographic and clinical characteristics of the study sample

After adjusting for covariates, COVID-19 survivors reported comparatively higher overall stigma levels (F(1,347) = 60.82, p < 0.001), and stigma in domains of social rejection (F(1,347) = 56.54, p < 0.001), financial insecurity (F(1,347) = 19.96, p < 0.001), internalized shame (F(1,347) = 71.40, p < 0.001) and social isolation (F(1,347) = 34.73, p < 0.001).

Correlates of overall stigma on COVID-19

Univariate analyses revealed that being COVID-19 survivors, having family members infected with COVID-19, gender, marital status, education level, employment status, perceptions of online mental service, economic loss, frequency of social media use and perceived health status were significantly associated with overall stigma (all p values < 0.05; Table 2). GLM analysis revealed that, apart from being COVID-19 survivors, having family members infected with COVID-19, married marital status, economic loss during the COVID-19 pandemic, and depressive symptoms were positively associated with greater overall stigma (all p values < 0.05; Fig. 1).

Table 2 Overall stigma by demographic characteristics in the whole sample (N = 348)
Fig. 1

Results of generalized linear model. Abbreviations: COVID-19: coronavirus disease 2019; PHQ-9: patient health questionnaire - 9 item; b: unstandardized regression coefficient; CI: confidence interval; β: standardized regression coefficient


To the best of our knowledge, this is the first study to compare differences in perceived stigma between COVID-19 survivors and healthy controls. We found that COVID-19 survivors experience significantly more overall stigma and heightened stigma in domains of social rejection, financial insecurity, internalized shame and social isolation compared with healthy controls. Our findings were similar to those based on previous outbreaks of severe infectious diseases such as SARS and the Ebola virus disease (EVD) [44]. Higher levels of perceived stigma in COVID-19 survivors could be attributed to worrying about transmitting the virus to family members, friends and colleagues and fear of being discriminated against or mistreated. Fear of transmission and discrimination may deter COVID-19 survivors from disclosing their infection status or history [10].

In this study, people who had COVID-19-infected family members also reported higher levels of stigma than those without, similar to evidence from Hubei residents indicating those who had quarantined friends were more likely to experience serious scrutiny and stigma during the COVID-19 outbreak [17]. The relationship between marital status and stigma has been mixed in the infectious disease literature. Married people reported higher levels of stigma than those who were unmarried, which is consistent with earlier findings from Singapore during the SARS outbreak wherein married healthcare workers perceived more severe social stigma than did unmarried peers and tended to believe that “people avoid my family because of my job” [32]. Nevertheless, no significant associations between marital status and stigma was found during outbreaks of other infectious diseases such as EVD [27, 59].

Previous research [17] found that Hubei residents, tuberculosis patients [1] and HIV patients [6], with higher socioeconomic status were less likely to report illness-related stigma. In line with these findings, people who had greater economic losses during the COVID-19 outbreak reported higher levels of stigma. Depression was also an independent correlate of COVID-19-related stigma in this study, consistent with evidence from the SARS outbreak [62] and HIV-positive patients [24, 38]. This relationship may be a partial reflection of shared core symptoms between depression and stigma including feelings of guilt, self-blame and low self-esteem [12, 52]. In addition, the relationship between depression and stigma is considered to be bi-directional based on several theoretical models of stigma and infectious disease or disability; i.e., stigma could increase the risk of depression, and vice versa [24, 36, 55, 60, 73].

The association between education level and infectious disease related stigma has been inconsistent between studies. For instance, some studies found that lower education is associated with increased stigma in patients with HIV [6], tuberculosis [1] or EVD [30] while other studies found complementary associations in patients with COVID-19 [17] or EVD [59]. James et al. found that educational level was not significantly associated with internalized or enacted stigma among Ebola survivors, paralleling results of this study [27].

Previous studies have also found that exposure to social media could help reduce HIV-related stigma [3, 7, 45]. However, we did not find significant associations between social media use / online mental services and COVID-19-related stigma. Our findings were similar to those of Duan et al. [17] who also reported an absence of such relations. Presumably, if social media releases misinformation and stigmatizing viewpoints to the lay public, the positive influence of media exposure on stigma could be offset [34, 64]. This assumption appears to have merit in light of evidence that misinformation and stigmatizing viewpoints have been common in social media during the COVID-19 pandemic, particularly in its early stages [21, 37].,

There are several methodological limitations in this study that should be acknowledged. First, because this was a cross-sectional study, causal relations between stigma and other variables could not be examined. Second, for logistical reasons, close contacts and family members of persons with COVID-19 cases were not analyzed separately. Third, although results documented correlates of perceived stigma, external stigma was not assessed in this study [1, 46, 65, 71]. Finally, convenience sampling of unmatched healthy controls from the community was undertaken to facilitate rapid data collection within the relatively narrow time window of the pandemic in which COVID-19 patients were also recruited. Consequently, the control group was unlikely to be representative of the population from which they were drawn and generalizations cannot be made from our sample to the uninfected population of Chongqing residents. Fortunately, key demographic measures were assessed in this study and potential confounding effects of group differences in demographics were statistically controlled within main analyses.

To reduce COVID-19-related stigma, health authorities and academic associations in many countries and territories have released appeals to stop stigmatizing at-risk groups including COVID-19 survivors, people returning from overseas and those released from quarantine [11, 41, 70]. These public health messages highlight negative consequences of stigma (e.g., reluctance to disclose infected status or seek assessment and treatment) that undermine efforts to treat the disease and mitigate further community spread [41]. Stigma also increases risks of fear, anger, discrimination, and violence toward ordinary people instead of devoting resources to eradicating the disease itself [11]. Underscoring the importance of communications to reduce stigma, the Mayo Clinic released a call entitled “What you can do to reduce COVID-19 stigma”, appealing for the public to access COVID-19 information from reputable sources such as the Centers for Disease Control and Prevention (CDC) and WHO, and provide support for people who may feel stigmatized [41]. CDC appeals have been made to community leaders and public health officials to prevent stigma by maintaining the privacy and confidentiality of COVID-19 survivors, correcting negative language that can cause stigma, and using media to challenge stereotyping and stigmatization [11]. The Washington State Department of Health has set up channels to report discrimination among those who encounter stigmatization or discrimination [63]. In China, some public media has also issued commentaries appealing to stop stigmatizing COVID-19 survivors [49]. In light of our results, continued public health appeals devoted to reducing COVID-19 stigma in China are clearly warranted.


In conclusion, COVID-19-related stigma is commonly experienced among COVID-19 survivors even though the outbreak has been well-contained in China. In light of our findings linking the COVID-19 diagnosis, economic losses, and depression with elevations in perceived stigma, routine assessment of perceived stigma should be conducted on COVID-19 survivors and other at-risk groups. Appropriate psychological assistance should be provided to those distressed by these experiences. In addition, science-based public health education and anti-stigma / anti-discrimination policies should be enacted and enforced in legal legislation to reduce stigmatizing responses of social institutions and the general public. Finally, the long-term impact of the COVID-19 pandemic on stigma should be examined in future studies with prospective research designs.

Availability of data and materials

The Clinical Research Ethics Committee of Chongqing Mental Health Center that approved the study prohibits the authors from making the research data set publicly available. Readers and all interested researchers may contact Dr. Guo-Qing Jiang (Email address: for details. Dr. Jiang could apply to the Clinical Research Ethics Committee of Chongqing Mental Health Center for the release of the data.



Social Impact Scale


Analysis of covariance


Analysis of variance


Unstandardized regression coefficient


Standardized regression coefficient


Coronavirus disease 2019


Confidence interval


Ebola virus disease


Generalized linear model


Human immunodeficiency virus


Patient health questionnaire - 9 item


Severe acute respiratory syndrome


Statistical Analysis System


  1. 1.

    Abioye I, Omotayo M, Alakija W. Socio-demographic determinants of stigma among patients with pulmonary tuberculosis in Lagos, Nigeria. Afr Health Sci. 2011;11(S1):S100–4.

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Adom, D., Adu Mensah, J., 2020. The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana. Social sciences & humanities open, available at SSRN: or (access 13 May 2020).

  3. 3.

    Aghaei A, Mohraz M, Shamshirband S. Effects of media, interpersonal communication and religious attitudes on HIV-related stigma in Tehran, Iran. Informatics in Medicine Unlocked. 2020;18:100291.

    Article  Google Scholar 

  4. 4.

    American Psychological Association, 2019. Discrimination: What it is, and how to cope. (access 31 Oct 2019).

  5. 5.

    Amnesty International, 2019. What drives discrimination and how do we stop it? , (access 13 Oct 2020).

  6. 6.

    Amuri M, Mitchell S, Cockcroft A, Andersson N. Socio-economic status and HIV/AIDS stigma in Tanzania. AIDS Care. 2011;23(3):378–82.

    Article  PubMed  Google Scholar 

  7. 7.

    Babalola S, Fatusi A, Anyanti J. Media saturation, communication exposure and HIV stigma in Nigeria. Soc Sci Med. 2009;68(8):1513–20.

    Article  PubMed  Google Scholar 

  8. 8.

    Bagcchi S. Stigma during the COVID-19 pandemic. Lancet Infect Dis. 2020;20(7):782.

    CAS  Article  Google Scholar 

  9. 9.

    Baldassarre A, Giorgi G, Alessio F, Lulli LG, Arcangeli G, Mucci N. Stigma and discrimination (SAD) at the time of the SARS-CoV-2 pandemic. Int J Environ Res Public Health. 2020;17(17):6341.

    CAS  Article  PubMed Central  Google Scholar 

  10. 10.

    Bu, N.-N., 2020. The 80 thousand COVID-19 survivers are undergoing discriminaton (in Chinese). (access 18 July 2020).

  11. 11.

    Centers for Disease Control and Prevention, 2020. Reducing Stigma. (access 11 June 2020).

  12. 12.

    Charles B, Jeyaseelan L, Pandian AK, Sam AE, Thenmozhi M, Jayaseelan V. Association between stigma, depression and quality of life of people living with HIV/AIDS (PLHA) in South India - a community based cross sectional study. BMC Public Health. 2012;12(1):463.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    China Daily, 2021. Latest data on novel coronavirus. (access 21 Mar 2021).

  14. 14.

    Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4(2):135–84.

    Article  PubMed  Google Scholar 

  15. 15.

    DingXiangYiSheng, 2021. COVID-19 Global Pandemic Real-time Report. (access 26 Feb 2021).

  16. 16.

    Do Duy C, Nong VM, Van AN, Thu TD, Do Thu N, Quang TN. COVID-19 related stigma and its association with mental health of health-care workers after quarantined in Vietnam. Psychiatry Clin Neurosci. 2020;74(10):566–8.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Duan W, Bu H, Chen Z. COVID-19-related stigma profiles and risk factors among people who are at high risk of contagion. Soc Sci Med. 2020;266:113425.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diab Metabol Syndrome. 2020;14(5):779–88.

    Article  Google Scholar 

  19. 19.

    Earnshaw VA, Brousseau NM, Hill EC, Kalichman SC, Eaton LA, Fox AB. Anticipated stigma, stereotypes, and COVID-19 testing. Stigma Health. 2020;5(4):390–3.

    Article  Google Scholar 

  20. 20.

    Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):50–67.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Geldsetzer P. Knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom: a cross-sectional online survey. Ann Intern Med. 2020;173(2):157–60.

    Article  PubMed  Google Scholar 

  22. 22.

    Gladman D, Nash P, Goto H, Birt JA, Lin CY, Orbai AM, et al. Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis. RMD Open. 2020;6(1):e000928.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Goffman, E., 1963. Stigma: notes on the management of spoiled identity. Prentice-Hall, United Kingdom.

  24. 24.

    Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010;22(5):630–9.

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Grover S, Singh P, Sahoo S, Mehra A. Stigma related to COVID-19 infection: are the health care workers stigmatizing their own colleagues? Asian J Psychiatr. 2020;53:102381.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Gu Y, Zhu Y, Xu F, Xi J, Xu G. Factors associated with mental health outcomes among patients with COVID-19 treated in the Fangcang shelter hospital in China. Asia Pac Psychiatr. 2020:e12443.

  27. 27.

    James PB, Wardle J, Steel A, Adams J. An assessment of Ebola-related stigma and its association with informal healthcare utilisation among Ebola survivors in Sierra Leone: a cross-sectional study. BMC Public Health. 2020;20(1):182.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Johns Hopkins University, 2020. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (access 7 Nov 2020).

    Google Scholar 

  29. 29.

    Kaufman KR, Petkova E, Bhui KS, Schulze TG. A global needs assessment in times of a global crisis: world psychiatry response to the COVID-19 pandemic. BJPsych Open. 2020;6(3):e48.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Kelly JD, Weiser SD, Wilson B, Cooper JB, Glayweon M, Sneller MC, et al. Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: an observational cohort study. PLoS Negl Trop Dis. 2019;13(2):e0007185.

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Kılınçel Ş, Kılınçel O, Muratdağı G, Aydın A, Usta MB. Factors affecting the anxiety levels of adolescents in home-quarantine during COVID-19 pandemic in Turkey. Asia Pac Psychiatr. 2020:e12406.

  32. 32.

    Koh D, Lim MK, Chia SE, Ko SM, Qian F, Ng V, et al. Risk perception and impact of severe acute respiratory syndrome (SARS) on work and personal lives of healthcare workers in Singapore: what can we learn? Med Care. 2005;43(7):676–82.

    Article  PubMed  Google Scholar 

  33. 33.

    Koschorke M, Evans-Lacko S, Sartorius N, Thornicroft G. Stigma in Different Cultures. In: Gaebel W, Rössler W, Sartorius N, editors. The stigma of mental illness - end of the story? Cham: Springer International Publishing; 2017. p. 67–82.

    Chapter  Google Scholar 

  34. 34.

    Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy gardens. Soc Sci Med. 2005;61(9):2038–46.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Levin S, Van Laar C. Stigma and group inequality: social psychological perspectives. New Jersey: Lawrence Erlbaum Associates, Inc.; 2006.

    Book  Google Scholar 

  36. 36.

    Li L, Lee SJ, Thammawijaya P, Jiraphongsa C, Rotheram-Borus MJ. Stigma, social support, and depression among people living with HIV in Thailand. AIDS Care. 2009;21(8):1007–13.

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Lin C-Y. Social reaction toward the 2019 novel coronavirus (COVID-19). Social Health and Behavior. 2020;3(1):1.

    Article  Google Scholar 

  38. 38.

    Logie C, James L, Tharao W, Loutfy M. Associations between HIV-related stigma, racial discrimination, gender discrimination, and depression among HIV-positive African, Caribbean, and black women in Ontario, Canada. AIDS Patient Care STDs. 2013;27(2):114–22.

    Article  PubMed  Google Scholar 

  39. 39.

    Ma Y, Zhan N. To mask or not to mask amid the COVID-19 pandemic: how Chinese students in America experience and cope with stigma. Chinese Sociological Review. 2020:1–26.

  40. 40.

    Mak WW, Cheung F, Woo J, Lee D, Li P, Chan KS, et al. A comparative study of the stigma associated with infectious diseases (SARS, AIDS, TB). Hong Kong Med J. 2009;15(Suppl 8):34–7.

    PubMed  Google Scholar 

  41. 41.

    Mayo Clinic, 2020. COVID-19 (coronavirus) stigma: what it is and how to reduce it., (access 17 Apr 2020).

  42. 42.

    Menon V, Padhy SK, Pattnaik JI. Stigma and aggression against health Care Workers in India Amidst COVID-19 times: possible drivers and mitigation strategies. Indian J Psychol Med. 2020;42(4):400–1.

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Misra S, Le PD, Goldmann E, Yang LH. Psychological impact of anti-Asian stigma due to the COVID-19 pandemic: a call for research, practice, and policy responses. Psychol Trauma Theory Res Pract Policy. 2020;12(5):461–4.

    Article  Google Scholar 

  44. 44.

    Muhidin S, Vizheh M, Moghadam ZB. Anticipating COVID-19-related stigma in survivors and health-care workers: lessons from previous infectious diseases outbreaks - an integrative literature review. Psychiatry Clin Neurosci. 2020;74(11):617–8.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    O'Leary A, Kennedy M, Pappas-DeLuca KA, Nkete M, Beck V, Galavotti C. Association between exposure to an HIV story line in the bold and the beautiful and HIV-related stigma in Botswana. AIDS Educ Prev. 2007;19(3):209–17.

    Article  PubMed  Google Scholar 

  46. 46.

    Overholt L, Wohl DA, Fischer WA 2nd, Westreich D, Tozay S, Reeves E, et al. Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study. PLoS One. 2018;13(11):e0206595.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Pan AW, Chung L, Fife BL, Hsiung PC. Evaluation of the psychometrics of the social impact scale: a measure of stigmatization. Int J Rehabil Res. 2007;30(3):235–8.

    Article  PubMed  Google Scholar 

  48. 48.

    Pan X, Xiao Y, Ren D, Xu ZM, Zhang Q, Yang LY, et al. Prevalence of mental health problems and associated risk factors among military healthcare workers in specialized COVID-19 hospitals in Wuhan, China: A cross-sectional survey. Asia Pac Psychiatr. 2020:e12427.

  49. 49.

    People's Daily, 2020. It is unhealthy to stigmatize COVID-19 survivors (in Chinese). (access 5 Mar 2020).

  50. 50.

    Peprah P, Gyasi RM. Stigma and COVID-19 crisis: a wake-up call. The International Journal of Health Planning and Management; 2020.

    Google Scholar 

  51. 51.

    Ramaci T, Barattucci M, Ledda C, Rapisarda V. Social stigma during COVID-19 and its impact on HCWs outcomes. Sustainability. 2020;12(9):3834.

    CAS  Article  Google Scholar 

  52. 52.

    Roeloffs C, Sherbourne C, Unützer J, Fink A, Tang L, Wells KB. Stigma and depression among primary care patients. Gen Hosp Psychiatry. 2003;25(5):311–5.

    Article  PubMed  Google Scholar 

  53. 53.

    Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16(1):57.

    Article  Google Scholar 

  54. 54.

    Salazar de Pablo G, Vaquerizo-Serrano J, Catalan A, Arango C, Moreno C, Ferre F, et al. Impact of coronavirus syndromes on physical and mental health of health care workers: systematic review and meta-analysis. J Affect Disord. 2020;275:48–57.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Shin J-S, Lee K-H, Kim K-S, Lee Y-I. The impact of perceived social stigma on depression among people with disabilities living in Chungbuk. J Community Welfare. 2011;36:361–85.

    Google Scholar 

  56. 56.

    Shoib S, Nagendrappa S, Grigo O, Rehman S, Ransing R. Factors associated with COVID-19 outbreak-related suicides in India. Asian J Psychiatr. 2020;53:102223.

    Article  PubMed  Google Scholar 

  57. 57.

    Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qual Health Res. 2008;18(6):729–38.

    Article  PubMed  Google Scholar 

  58. 58.

    Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. Jama. 1999;282(18):1737–44.

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Tenkorang EY. Ebola-related stigma in Ghana: individual and community level determinants. Soc Sci Med. 2017;182:142–9.

    Article  PubMed  Google Scholar 

  60. 60.

    Turan B, Smith W, Cohen MH, Wilson TE, Adimora AA, Merenstein D, et al. Mechanisms for the negative effects of internalized HIV-related stigma on antiretroviral therapy adherence in women: the mediating roles of social isolation and depression. J Acquir Immune Defic Syndr. 2016;72(2):198–205.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Venugopal, V.C., Mohan, A., Chennabasappa, L.K., 2020. Status of mental health and its associated factors among the general populace of India during COVID-19 pandemic. Asia Pac psychiatry, e12412.

  62. 62.

    Verma S, Mythily S, Chan YH, Deslypere JP, Teo EK, Chong SA. Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore. Ann Acad Med Singap. 2004;33(6):743–8.

    CAS  PubMed  Google Scholar 

  63. 63.

    Washington State Department of Health, 2020. Stigma Reduction. (access 28 Feb 2021).

  64. 64.

    Williams J, Gonzalez-Medina D. Infectious diseases and social stigma. Applied Innovations and Technologies. 2011;4(1):58–70.

    Article  Google Scholar 

  65. 65.

    Wolitski RJ, Pals SL, Kidder DP, Courtenay-Quirk C, Holtgrave DR. The effects of HIV stigma on health, disclosure of HIV status, and risk behavior of homeless and unstably housed persons living with HIV. AIDS Behav. 2009;13(6):1222–32.

    Article  PubMed  Google Scholar 

  66. 66.

    World Health Organization, 2020a. Naming the coronavirus disease (COVID-19) and the virus that causes it. (access 11 Feb 2020).

    Google Scholar 

  67. 67.

    World Health Organization, 2020b. Novel Coronavirus – China. (access 12 Jan 2020).

    Google Scholar 

  68. 68.

    World Health Organization, 2020c. When talking about #COVID19, certain words & language may have a negative meaning for people and fuel stigmatizing attitudes [Twitter post]. (access 2 Mar 2020).

  69. 69.

    World Health Organization, 2020d. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. (access 11 Mar 2020).

  70. 70.

    World Health Organization, 2020e. A guide to preventing and addressing social stigma associated with COVID-19. (access 24 Feb 2020).

  71. 71.

    Wright K, Naar-King S, Lam P, Templin T, Frey M. Stigma scale revised: reliability and validity of a brief measure of stigma for HIV+ youth. J Adolesc Health. 2007;40(1):96–8.

    Article  PubMed  Google Scholar 

  72. 72.

    Xu Y, Wu HS, Xu YF. The application of patient health questionnaire 9 in community elderly population: reliability and validity. Shanghai Archives Psychiatr. 2007;19(05):257 259+276.

    Google Scholar 

  73. 73.

    Yıldırım Z, Ertem DH, Ceyhan Dirican A, Baybaş S. Stigma accounts for depression in patients with epilepsy. Epilepsy Behav. 2018;78:1–6.

    Article  PubMed  Google Scholar 

  74. 74.

    Zandifar A, Badrfam R, Khonsari NM, Mohammadi MR, Asayesh H, Qorbani M. Prevalence and associated factors of posttraumatic stress symptoms and stigma among health care workers in contact with COVID-19 patients. Iran J Psychiatry. 2020;15(4):355–65.

    Google Scholar 

Download references



Authors’ contributors

Study design: Yuan Yuan, Guo-Qing Jiang, Yu-Tao Xiang. Data collection, analysis and interpretation: Yuan Yuan, Yan-Jie Zhao, Qing-E Zhang, Ling Zhang. Drafting of the manuscript: Yan-Jie Zhao, Teris Cheung, Yu-Tao Xiang. Critical revision of the manuscript: Todd Jackson. Approval of the final version for publication: all co-authors.


The study was supported by the National Science and Technology Major Project for investigational new drug (2018ZX09201–014), the Beijing Municipal Science & Technology Commission (No. Z181100001518005), and the University of Macau (MYRG2019–00066-FHS).

Author information



Corresponding authors

Correspondence to Guo-Qing Jiang or Yu-Tao Xiang.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by the ethics committee of the Chongqing Mental Health Center. All participants provided online informed consent prior to participation.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yuan, Y., Zhao, YJ., Zhang, QE. et al. COVID-19-related stigma and its sociodemographic correlates: a comparative study. Global Health 17, 54 (2021).

Download citation


  • COVID-19 survivors
  • Stigma